Greenwood Gearhart’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,183
| Closed | -$34.1K | – | 226 |
|
|
2023
Q4 | $34.1K | Buy |
+1,183
| New | +$35.8K | ﹤0.01% | 180 |
|
|
2023
Q2 | – | Sell |
-5,492
| Closed | -$224K | – | 100 |
|
|
2023
Q1 | $224K | Sell |
5,492
-376
| -6% | -$16.2K | 0.03% | 92 |
|
|
2022
Q4 | $301K | Buy |
+5,868
| New | +$281K | 0.04% | 86 |
|
|
2022
Q3 | – | Sell |
-3,868
| Closed | -$203K | – | 97 |
|
|
2022
Q2 | $203K | Buy |
+3,868
| New | +$197K | 0.03% | 91 |
|
|
2022
Q1 | – | Sell |
-3,850
| Closed | -$227K | – | 103 |
|
|
2021
Q4 | $227K | Buy |
+3,850
| New | +$191K | 0.03% | 95 |
|
|
2020
Q1 | – | Sell |
-220,644
| Closed | -$8.2M | – | 72 |
|
|
2019
Q4 | $8.2M | Buy |
220,644
+4,451
| +2% | +$159K | 2.12% | 16 |
|
|
2019
Q3 | $7.37M | Buy |
216,193
+7,418
| +4% | +$270K | 2.03% | 18 |
|
|
2019
Q2 | $8.58M | Buy |
208,775
+3,657
| +2% | +$145K | 2.3% | 14 |
|
|
2019
Q1 | $8.27M | Buy |
205,118
+337
| +0.2% | +$13.5K | 2.42% | 14 |
|
|
2018
Q4 | $8.48M | Sell |
204,781
-21,453
| -9% | -$891K | 2.82% | 6 |
|
|
2018
Q3 | $9.46M | Buy |
226,234
+2,864
| +1% | +$110K | 2.65% | 4 |
|
|
2018
Q2 | $7.69M | Buy |
223,370
+5,325
| +2% | +$182K | 2.3% | 16 |
|
|
2018
Q1 | $7.34M | Buy |
218,045
+14,969
| +7% | +$515K | 2.24% | 17 |
|
|
2017
Q4 | $6.98M | Buy |
203,076
+22,404
| +12% | +$764K | 2.22% | 19 |
|
|
2017
Q3 | $6.12M | Buy |
180,672
+11,167
| +7% | +$359K | 2.21% | 18 |
|
|
2017
Q2 | $5.4M | Buy |
169,505
+68
| +0% | +$2.14K | 2.06% | 26 |
|
|
2017
Q1 | $5.5M | Buy |
169,437
+8,522
| +5% | +$269K | 2.06% | 24 |
|
|
2016
Q4 | $4.96M | Sell |
160,915
-427
| -0.3% | -$13K | 2.02% | 26 |
|
|
2016
Q3 | $5.18M | Sell |
161,342
-4,823
| -3% | -$161K | 2.13% | 22 |
|
|
2016
Q2 | $5.55M | Sell |
166,165
-1,466
| -0.9% | -$46.8K | 2.35% | 13 |
|
|
2016
Q1 | $4.71M | Buy |
167,631
+1,892
| +1% | +$54K | 2.03% | 27 |
|
|
2015
Q4 | $5.08M | Sell |
165,739
-3,741
| -2% | -$118K | 2.27% | 16 |
|
|
2015
Q3 | $5.05M | Sell |
169,480
-599
| -0.4% | -$19.2K | 2.4% | 14 |
|
|
2015
Q2 | $5.41M | Sell |
170,079
-1,048
| -0.6% | -$34.2K | 2.42% | 14 |
|
|
2015
Q1 | $5.65M | Sell |
171,127
-3,342
| -2% | -$106K | 2.46% | 12 |
|
|
2014
Q4 | $5.16M | Buy |
174,469
+5,128
| +3% | +$147K | 2.3% | 21 |
|
|
2014
Q3 | $4.75M | Buy |
169,341
+4,800
| +3% | +$135K | 2.18% | 24 |
|
|
2014
Q2 | $4.63M | Buy |
164,541
+9,206
| +6% | +$262K | 2.25% | 22 |
|
|
2014
Q1 | $4.73M | Sell |
155,335
-820
| -0.5% | -$24.4K | 2.34% | 10 |
|
|
2013
Q4 | $4.54M | Buy |
156,155
+27
| +0% | +$786 | 2.36% | 11 |
|
|
2013
Q3 | $4.25M | Buy |
156,128
+506
| +0.3% | +$13.8K | 2.48% | 11 |
|
|
2013
Q2 | $4.14M | Buy |
+155,622
| New | +$4.3M | 2.54% | 11 |
|
Other funds holding PFE
Greenwood Gearhart's PFE Position: Q1 2024 in Review
Greenwood Gearhart sold out of Pfizer (PFE) in Q1 2024, closing a stake of 1,183 shares — an estimated $34.1K sold.
Greenwood Gearhart first reported a position in PFE in Q2 2013 and held it in 32 quarters. The position peaked at $9.46M in Q3 2018. 2,875 funds tracked by Wall St. Rank hold PFE as of Q1 2024.
- Greenwood Gearhart reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
- Greenwood Gearhart sold 1,183 Pfizer shares in Q1 2024, an estimated $34.1K.
- Greenwood Gearhart first reported a position in Pfizer in Q2 2013 and held it in 32 quarters.
- Greenwood Gearhart's Pfizer position peaked at $9.46M in Q3 2018.
- 2,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.
Based on Greenwood Gearhart's 13F filing for Q1 2024, filed 15 May 2024.